# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA707924 | F | Compound was evaluated for antigen specific activity in vitro L2987 cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
2. | ALA707925 | F | In vitro inhibitory concentration of the BR96 conjugate of compound against human L2987 lung carcinoma cell line | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
3. | ALA707926 | F | In vitro inhibitory concentration of the IgG conjugate of compound against human L2987 lung carcinoma cell line | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
4. | ALA707927 | F | In vitro inhibitory concentration of the unconjugated compound against human L2987 lung carcinoma cell line | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
5. | ALA707928 | F | Potency against human L2987 lung carcinoma cell line relative to that of BR96-1b | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
6. | ALA707929 | F | Potency against human L2987 lung carcinoma cell line relative to that of BR96-1b | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
7. | ALA707930 | F | Potency against human L2987 lung carcinoma cell line relative to that of DOX 1a | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
8. | ALA866818 | F | Antiproliferative activity against L2987 cells | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
9. | ALA868111 | F | Inhibition of tumor growth in Athymic mouse xenografted with L2987 at 60 mg/kg after 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
10. | ALA868112 | F | Inhibition of tumor growth in Athymic mouse xenografted with L2987 at 90 mg/kg after 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
11. | ALA868113 | F | Inhibition of tumor growth in Athymic mouse xenografted with L2987 at 180 mg/kg after 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
12. | ALA868114 | F | Inhibition of tumor growth in Athymic mouse xenografted with L2987 at 25 mg/kg after 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
13. | ALA868115 | F | Inhibition of tumor growth in Athymic mouse xenografted with L2987 at 50 mg/kg after 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
14. | ALA926198 | F | Cytotoxicity against human L2987 cells | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
15. | ALA926199 | F | Cytotoxicity against human L2987 cells in presence of DTT | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
16. | ALA950146 | F | Antitumor activity against human L2987 cells xenografted athymic mouse at 30 mg/kg, po administered once daily for 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
17. | ALA950147 | F | Antitumor activity against human L2987 cells xenografted athymic mouse at 90 mg/kg, po administered once daily for 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
18. | ALA935257 | F | Antitumor activity against human L2987 cells xenografted po dosed athymic mouse after 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
19. | ALA935258 | F | Antitumor activity against human L2987 cells xenografted athymic mouse at 80 mg/kg/day, po after 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
20. | ALA935259 | F | Antitumor activity against human L2987 cells xenografted athymic mouse at 107 mg/kg/day, po after 14 days | Homo sapiens | 1 | organism-based format | Scientific Literature |